MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 154 filers reported holding MACROGENICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,568,428 | -12.9% | 1,409,534 | +0.0% | 0.04% | -8.7% |
| Q2 2023 | $7,538,418 | -20.4% | 1,409,050 | +6.6% | 0.05% | -22.0% |
| Q1 2023 | $9,473,147 | -37.0% | 1,321,220 | -41.1% | 0.06% | -41.6% |
| Q4 2022 | $15,046,249 | +50.0% | 2,242,362 | -22.7% | 0.10% | +44.3% |
| Q3 2022 | $10,034,000 | -22.5% | 2,900,049 | -33.9% | 0.07% | -14.6% |
| Q2 2022 | $12,951,000 | -63.6% | 4,390,064 | +8.6% | 0.08% | -53.1% |
| Q1 2022 | $35,604,000 | -46.0% | 4,041,339 | -1.6% | 0.18% | -34.9% |
| Q4 2021 | $65,945,000 | -27.1% | 4,108,701 | -4.9% | 0.27% | -26.9% |
| Q3 2021 | $90,441,000 | -18.2% | 4,319,051 | +4.9% | 0.37% | -18.0% |
| Q2 2021 | $110,597,000 | -15.4% | 4,117,517 | +0.4% | 0.45% | -23.5% |
| Q1 2021 | $130,678,000 | +55.7% | 4,102,915 | +11.7% | 0.59% | +42.1% |
| Q4 2020 | $83,952,000 | +36.9% | 3,672,416 | +50.9% | 0.41% | +5.9% |
| Q3 2020 | $61,305,000 | -5.0% | 2,433,724 | +5.3% | 0.39% | -16.5% |
| Q2 2020 | $64,539,000 | +324.4% | 2,311,582 | -11.5% | 0.47% | +195.6% |
| Q1 2020 | $15,208,000 | -36.4% | 2,613,035 | +18.9% | 0.16% | -19.4% |
| Q4 2019 | $23,911,000 | +33.4% | 2,197,701 | +56.4% | 0.20% | +14.6% |
| Q3 2019 | $17,926,000 | -25.7% | 1,404,870 | -1.2% | 0.17% | -27.2% |
| Q2 2019 | $24,135,000 | +3.9% | 1,422,245 | +10.1% | 0.24% | -7.1% |
| Q1 2019 | $23,221,000 | +75.0% | 1,291,513 | +23.6% | 0.25% | +42.9% |
| Q4 2018 | $13,271,000 | -40.8% | 1,044,977 | -0.1% | 0.18% | -30.9% |
| Q3 2018 | $22,435,000 | +7.5% | 1,046,397 | +3.5% | 0.26% | +2.0% |
| Q2 2018 | $20,879,000 | -18.2% | 1,011,100 | -0.4% | 0.25% | -23.9% |
| Q1 2018 | $25,538,000 | +30.7% | 1,015,036 | -1.3% | 0.33% | +27.4% |
| Q4 2017 | $19,540,000 | +1.3% | 1,028,443 | -1.5% | 0.26% | -1.1% |
| Q3 2017 | $19,297,000 | +5.5% | 1,044,231 | -0.0% | 0.26% | +2.7% |
| Q2 2017 | $18,285,000 | +4855.3% | 1,044,243 | +5159.3% | 0.26% | +5000.0% |
| Q1 2017 | $369,000 | – | 19,855 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |